Natural environments may cut hospitalization for patients with neurodegenerative diseases
Dec 30, 2022
The normalized difference vegetation index was negatively associated with hospitalization for Alzheimer’s disease and related dementia as well as Parkinson’s disease.
Cardiac 18F-dopamine PET can predict Lewy body diseases
Nov 15, 2023
All nine LBD+ participants had low 18F-dopamine-derived radioactivity before or at the time of diagnosis of central Lewy body disease.
Dopamine agonists, DRIs similar for quality of life in Parkinson’s disease
Dec 29, 2021
The research “suggests that MAO-B inhibitors might be underused as adjuvant therapy for the treatment of people with Parkinson disease.”
COVID-19 linked to increased risk of neurological disorders
Jun 30, 2022
Most neurological disorders do not appear to be more frequent after COVID-19 than after influenza or bacterial pneumonia
ENT-01 safe, improves constipation in patients with Parkinson’s disease
Nov 07, 2022
Improvement was seen in the weekly complete spontaneous bowel movement rate and in secondary end points
.
17 percent of patients seeing neurologist travel long distance
Sep 13, 2023
Factors associated with long-distance travel include low neurologist density, rural setting and visits for ALS and nervous system cancer.
Hospital-treated infections earlier in life tied to Alzheimer’s, Parkinson’s disease risk
Sep 28, 2022
An association was found for Alzheimer’s and Parkinson’s disease cases diagnosed before 60 years of age.
Allopurinol may cut risk for neurodegenerative diseases
May 19, 2023
Allopurinol linked to 13 to 34 percent lower risk for Parkinson disease, Alzheimer disease, ALS
Alzheimer’s, Parkinson’s disease share protective association at HLA locus
Sep 08, 2023
Protective HLA-DRB1*04 subtypes bind strongly to aggregation-prone tau PHF6 sequence when acetylated at K311.